Spain
· Delayed Price · Currency is EUR BME:YSRR Statistics
Total Valuation
BME:YSRR has a market cap or net worth of EUR 98.71 million. The enterprise value is 133.73 million.
| Market Cap | 98.71M |
| Enterprise Value | 133.73M |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:YSRR has 4.99 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 4.99M |
| Shares Outstanding | 4.99M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.19M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.10 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -71.20 |
| EV / Sales | 27.23 |
| EV / EBITDA | 93.29 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03, with a Debt / Equity ratio of 0.78.
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 24.82 |
| Debt / FCF | n/a |
| Interest Coverage | 0.08 |
Financial Efficiency
Return on equity (ROE) is -4.02% and return on invested capital (ROIC) is 0.12%.
| Return on Equity (ROE) | -4.02% |
| Return on Assets (ROA) | 0.12% |
| Return on Invested Capital (ROIC) | 0.12% |
| Return on Capital Employed (ROCE) | 0.30% |
| Revenue Per Employee | 4.91M |
| Profits Per Employee | -1.88M |
| Employee Count | 1 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.48% in the last 52 weeks. The beta is 0.01, so BME:YSRR's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -7.48% |
| 50-Day Moving Average | 19.80 |
| 200-Day Moving Average | 20.17 |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YSRR had revenue of EUR 4.91 million and -1.88 million in losses.
| Revenue | 4.91M |
| Gross Profit | 2.46M |
| Operating Income | 156,096 |
| Pretax Income | -1.88M |
| Net Income | -1.88M |
| EBITDA | 1.43M |
| EBIT | 156,096 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 558,498 in cash and 35.57 million in debt, giving a net cash position of -35.01 million or -7.02 per share.
| Cash & Cash Equivalents | 558,498 |
| Total Debt | 35.57M |
| Net Cash | -35.01M |
| Net Cash Per Share | -7.02 |
| Equity (Book Value) | 45.73M |
| Book Value Per Share | n/a |
| Working Capital | -29.57M |
Cash Flow
| Operating Cash Flow | -366,539 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 50.06%, with operating and profit margins of 3.18% and -38.24%.
| Gross Margin | 50.06% |
| Operating Margin | 3.18% |
| Pretax Margin | -38.24% |
| Profit Margin | -38.24% |
| EBITDA Margin | 29.19% |
| EBIT Margin | 3.18% |
| FCF Margin | n/a |
Dividends & Yields
BME:YSRR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | -1.90% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |